The Vanguard Group 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-10 12:15 pm Purchase | 2024-05-31 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 4,687,393 10.570% | 13,715 (+0.29%) | Filing |
| 2024-02-13 5:15 pm Purchase | 2023-12-29 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 4,673,678 9.950% | 192,959 (+4.31%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 4,480,719 9.830% | 319,756 (+7.68%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 4,160,963 9.240% | 196,962 (+4.97%) | Filing |
| 2021-02-10 11:57 am Sale | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 3,964,001 8.920% | -88,046 (-2.17%) | Filing |
| 2020-02-12 07:57 am Purchase | 2019-12-31 | 13G | United Therapeutics Corporation UTHR | The Vanguard Group | 4,052,047 9.230% | 144,768 (+3.71%) | Filing |